Harwood Feffer LLP Announces Investigation of BioClinica, Inc.

        Harwood Feffer LLP Announces Investigation of BioClinica, Inc.

PR Newswire

NEW YORK, Jan. 30, 2013

NEW YORK, Jan. 30, 2013 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is
investigating potential claims against the board of directors of BioClinica,
Inc. ("BIOC" or the "Company") (NASDAQ: BIOC) concerning the proposed
acquisition of the Company by JLL Partners ("JLL") in a transaction valued at
approximately $123 million. 

(Logo: http://photos.prnewswire.com/prnh/20120215/MM54604LOGO)

On January 30, 2013, BioClinica announced that it had entered into a
definitive agreement pursuant to which the Company will be acquired by JLL.
Under the terms of the agreement, BioClinica shareholders will receive $7.25
for each share owned.

Our investigation concerns whether the BioClinica board of directors is
fulfilling its fiduciary duties, maximizing the value of the Company,
disclosing all material benefits and costs, and obtaining full and fair
consideration for Company shareholders.

If you own BioClinica shares and wish to discuss this matter with us, or have
any questions concerning your rights and interests with regard to this matter,
please contact:

Benjamin Sachs-Michaels, Esq.
Robert I. Harwood, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com

Harwood Feffer has been representing individual and institutional investors
for many years, serving as lead counsel in numerous cases in federal and state
courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for
more information about the firm.

Attorney Advertising © 2013 Harwood Feffer LLP. The law firm responsible for
this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not
guarantee or predict a similar outcome with respect to any future matter.

SOURCE Harwood Feffer LLP

Website: http://www.hfesq.com